Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.081 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.7 |